Leo J Hofland Selected Research

Circulating Tumor DNA

1/2019	Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.
10/2017	Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case Series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leo J Hofland Research Topics

Disease

72	Neoplasms (Cancer) 01/2024 - 12/2002
26	Pituitary Neoplasms (Pituitary Adenoma) 01/2024 - 12/2003
25	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023 - 02/2003
20	Adenoma (Adenomas) 06/2020 - 01/2003
15	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 05/2006
13	Cushing Syndrome 03/2024 - 08/2002
12	Acromegaly 01/2023 - 12/2002
12	Pituitary ACTH Hypersecretion 06/2013 - 01/2004
11	Adrenocortical Carcinoma 07/2023 - 11/2006
9	ACTH-Secreting Pituitary Adenoma 01/2021 - 01/2004
7	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2005
6	Carcinoid Tumor (Carcinoid) 12/2023 - 12/2002
6	Growth Hormone-Secreting Pituitary Adenoma 09/2022 - 02/2003
6	Prolactinoma (Prolactinomas) 08/2019 - 01/2004
5	Hyperplasia 08/2014 - 01/2003
4	Fibrosis (Cirrhosis) 04/2022 - 01/2018
4	Insulin Resistance 10/2017 - 10/2009
4	Carcinoma (Carcinomatosis) 11/2010 - 09/2004
3	medullary Thyroid cancer 09/2022 - 01/2017
3	Thyroid Neoplasms (Thyroid Cancer) 03/2021 - 01/2017
3	Primitive Neuroectodermal Tumors (PNET) 03/2018 - 04/2015
3	Pheochromocytoma 01/2014 - 01/2004
3	Wounds and Injuries (Trauma) 01/2007 - 12/2004
2	Necrosis 08/2019 - 01/2017
2	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2019 - 01/2014
2	Gastro-enteropancreatic neuroendocrine tumor 01/2016 - 01/2016
2	Adenocarcinoma 01/2015 - 08/2007
2	Islet Cell Adenoma (Islet Cell Tumors) 02/2003 - 12/2002

Drug/Important Bio-Agent (IBA)

37	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023 - 12/2002
35	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2024 - 12/2002
20	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 08/2002
18	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2024 - 01/2003
15	Messenger RNA (mRNA)IBA 12/2023 - 01/2003
15	Octreotide (Sandostatin)FDA LinkGeneric 01/2023 - 12/2002
11	pasireotideIBA 06/2020 - 01/2004
10	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 04/2008
10	Hormones (Hormone)IBA 01/2021 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2013
9	Cabergoline FDA LinkGeneric 01/2023 - 05/2004
9	Interferon Type IIBA 03/2021 - 11/2006
9	Dopamine Agonists (Dopamine Agonist)IBA 08/2019 - 05/2004
8	Growth Hormone (Somatotropin)IBA 01/2023 - 04/2004
8	Dopamine Receptors (Dopamine Receptor)IBA 02/2013 - 05/2004
7	Insulin-Like PeptidesIBA 07/2023 - 01/2015
7	Radioisotopes (Radionuclides)IBA 09/2021 - 12/2002
6	Peptide Receptors (Peptide Receptor)IBA 09/2021 - 01/2005
6	Insulin (Novolin)FDA Link 01/2021 - 10/2009
6	InterferonsIBA 01/2015 - 11/2006
5	LigandsIBA 01/2024 - 04/2005
5	ProlactinIBA 01/2023 - 04/2004
5	Insulin-Like Growth Factor I (IGF-1)IBA 06/2020 - 02/2010
4	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 01/2012
4	Gemcitabine FDA Link 08/2022 - 05/2013
4	Ketoconazole (Nizoral)FDA LinkGeneric 01/2021 - 05/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2009
4	GhrelinIBA 01/2017 - 06/2006
3	ArrestinsIBA 01/2024 - 12/2013
3	ParaffinIBA 07/2023 - 01/2015
3	somatostatin receptor 2IBA 01/2023 - 01/2009
3	lanreotide (Somatuline)FDA Link 01/2021 - 01/2004
3	Temozolomide (Temodar)FDA LinkGeneric 10/2020 - 11/2010
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2017
3	Mitotane (Lysodren)FDA Link 01/2020 - 06/2013
3	MTOR InhibitorsIBA 01/2019 - 06/2012
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2016 - 12/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2007 - 01/2007
3	CytokinesIBA 09/2006 - 12/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006 - 12/2004
2	GlucocorticoidsIBA 03/2024 - 01/2004
2	Formaldehyde (Formol)FDA Link 07/2023 - 09/2022
2	ProteomeIBA 01/2023 - 04/2022
2	Tyrosine Kinase InhibitorsIBA 09/2022 - 04/2019
2	somatostatin receptor 5IBA 05/2022 - 04/2005
2	Serotonin (5 Hydroxytryptamine)IBA 04/2022 - 01/2020
2	Histone Deacetylase InhibitorsIBA 02/2022 - 09/2021
2	SteroidsIBA 01/2022 - 01/2021
2	pegvisomant FDA LinkGeneric 06/2020 - 01/2017
2	177Lu-octreotateIBA 04/2019 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2003
2	Circulating Tumor DNAIBA 01/2019 - 10/2017
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2017 - 03/2012
2	Ghrelin ReceptorsIBA 01/2017 - 06/2006
2	Everolimus FDA Link 01/2017 - 03/2016
2	Sirolimus (Rapamycin)FDA Link 06/2016 - 08/2014
2	ArrestinIBA 05/2016 - 12/2013
2	Insulin ReceptorIBA 01/2016 - 01/2015
2	Protein Isoforms (Isoforms)IBA 01/2016 - 09/2004
2	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2015 - 03/2014
2	Angiotensin IIIBA 09/2013 - 09/2004
2	EnzymesIBA 09/2013 - 01/2007
2	CatecholaminesIBA 09/2013 - 08/2002
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2013 - 01/2012
2	Monoclonal AntibodiesIBA 01/2013 - 12/2004
2	AndrogensIBA 01/2013 - 09/2004
2	Interleukin-6 (Interleukin 6)IBA 09/2006 - 05/2006

Therapy/Procedure

32	Therapeutics 03/2024 - 02/2003
8	Radiotherapy 01/2023 - 12/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 02/2003